Victoria Higgins, Angela W.S. Fung, Man Khun Chan, Joseph Macri and Khosrow Adeli

Corrigendum to: Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents

Accessible
De Gruyter | Published online: February 12, 2020

Corrigendum to: Higgins V, Fung AWS, Chan MK, Macri J, Adeli K. Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents. Clinical Chemistry and Laboratory Medicine 2018; volume 56, Issue 2, pp. 327–340. (DOI: https://doi.org/10.1515/cclm-2017-0349).

  1. Table 1 (SI units) in the original article contains incorrect values for the progesterone reference interval for males aged 15 to <19 years. Corrected progesterone reference intervals are provided below in the corrected Table 1 (SI Units).

  2. Supplementary Table 2 (CON units) in the original article therefore also contains incorrect values for the progesterone reference interval for males aged 15 to <19 years. Additionally, the upper progesterone reference limit for 11 to <15 years, the female progesterone 15 to <19 years sample size, the TSH reference interval for 0 to <1 week, and the iPTH reference intervals contained errors. Corrected reference intervals are provided below in the corrected Supplementary Table 2 (CON units).

  3. While labeled as μg/L, the y-axis values for Troponin I in Figure 7A were displayed as ng/L. The correct y-axis is shown in the corrected Figure 7A below:

Corrected Table 1 (SI units).

AnalyteFemale reference intervalsMale reference intervals
AgeLower limitUpper limitnLower 90% confidence intervalUpper 90% confidence intervalAgeLower limitUpper limitnLower 90% confidence intervalUpper 90% confidence interval
Progesterone, nmol/L0 to <2 weeks7.9>17860(2.5, 15)NA0 to <2 weeks7.9>17860(2.5, 15)NA
2 weeks to –<11 years0.4912312(0.47, 0.57)(6.6, 17)2 weeks to <11 years0.4912312(0.47, 0.57)(6.6, 17)
11 to <15 years1.113138(1.0, 1.5)(7.8, 15)11 to <15 years1.113138(1.0, 1.5)(7.8, 15)
15 to <19 years2.331.079(2.2, 2.5)(12, 33)15 to <19 years2.89.179(2.5, 3.0)(8.4, 9.8)

Corrected Supplementary Table 2 (CON units).

AnalyteFemale reference intervalsMale reference intervals
AgeLower limitUpper limitnLower 90% confidence intervalUpper 90% confidence intervalAgeLower limitUpper limitnLower 90% confidence intervalUpper 90% confidence interval
Progesterone, nmol/L0 to <2 weeks2.50>5660(0.78, 4.83)NA0 to <2 weeks2.50>5660(0.78, 4.80)NA
2 weeks to <11 years0.153.8312(0.15, 0.18)(2.1, 5.4)2 weeks to <11 years0.153.8312(0.15, 0.18)(2.1, 5.4)
11 to <15 years0.354.09138(0.32, 0.48)(2.5, 4.6)11 to <15 years0.354.09138(0.32, 0.48)(2.5, 4.6)
15 to <19 years0.739.879(0.69, 0.79)(8.1, 12)15 to <19 years0.882.979(0.79, 0.94)(2.6, 3.1)
iPTH, pg/mL0 to <2 weeks5.3810845(4.43, 7.45)(87.7, 124)0 to <2 weeks5.3810845(4.43, 7.45)(87.7, 124)
2 weeks to <9 years11.667.4203(10.4, 13.5)(60.7, 75.1)2 weeks to <9 years11.667.4203(10.4, 13.5)(60.7, 75.1)
9 to <15 years17.9122269(16.2, 18.3)(95.2, 131)9 to <15 years17.9122269(16.2, 18.3)(95.2, 131)
15 to <19 years13.662.984(12.3, 15.7)(53.2, 70.6)15 to <19 yrs15.779.382(14.3, 16.7)(71.7, 86.6)
TSH, μIU/mL0 to <1 week0.7131.551(0.31, 1.40)(25.9, 37.5)0 to <1 week0.7131.551(0.31, 1.40)(25.9, 37.5)
1 week to <19 years0.865.70600(0.77, 0.94)(5.37, 6.28)1 week to <19 years0.865.70600(0.77, 0.94)(5.37, 6.28)
Figure 7A.  

Figure 7A.

Published Online: 2020-02-12
Published in Print: 2020-03-26

©2020 Walter de Gruyter GmbH, Berlin/Boston